These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7024051)

  • 1. Drug targeting: magnetically responsive albumin microspheres--a review of the system to date.
    Senyei AE; Widder KJ
    Gynecol Oncol; 1981 Aug; 12(1):1-13. PubMed ID: 7024051
    [No Abstract]   [Full Text] [Related]  

  • 2. Albumin microspheres as drug carriers.
    Morimoto Y; Fujimoto S
    Crit Rev Ther Drug Carrier Syst; 1985; 2(1):19-63. PubMed ID: 3913529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of drug delivery following the administration of magnetic albumin microspheres containing adriamycin to the rat.
    Gallo JM; Gupta PK; Hung CT; Perrier DG
    J Pharm Sci; 1989 Mar; 78(3):190-4. PubMed ID: 2724075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor remission in Yoshida sarcoma-bearing rts by selective targeting of magnetic albumin microspheres containing doxorubicin.
    Widder KJ; Morris RM; Poore G; Howard DP; Senyei AE
    Proc Natl Acad Sci U S A; 1981 Jan; 78(1):579-81. PubMed ID: 6941258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective targeting of magnetic albumin microspheres containing low-dose doxorubicin: total remission in Yoshida sarcoma-bearing rats.
    Widder KJ; Morris RM; Poore GA; Howard DP; Senyei AE
    Eur J Cancer Clin Oncol; 1983 Jan; 19(1):135-9. PubMed ID: 6682771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro release of biologically active adriamycin by magnetically responsive albumin microspheres.
    Widder KJ; Senyei AE; Ranney DF
    Cancer Res; 1980 Oct; 40(10):3512-7. PubMed ID: 7438037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective targeting of magnetic albumin microspheres to the Yoshida sarcoma: ultrastructural evaluation of microsphere disposition.
    Widder KJ; Marino PA; Morris RM; Howard DP; Poore GA; Senyei AE
    Eur J Cancer Clin Oncol; 1983 Jan; 19(1):141-7. PubMed ID: 6682772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetically responsive microspheres and other carriers for the biophysical targeting of antitumor agents.
    Widder KJ; Senyei AE; Ranney DF
    Adv Pharmacol Chemother; 1979; 16():213-71. PubMed ID: 382799
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of a syngeneic rat tumor with magnetically responsive albumin microspheres labeled with doxorubicin or protein A.
    Rettenmaier MA; Stratton JA; Berman ML; Senyei A; Widder K; White DB; DiSaia PJ
    Gynecol Oncol; 1987 May; 27(1):34-43. PubMed ID: 3570048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted delivery of low dose doxorubicin hydrochloride administered via magnetic albumin microspheres in rats.
    Gupta PK; Hung CT
    J Microencapsul; 1990; 7(1):85-94. PubMed ID: 2308056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Target organ disposition and plasma pharmacokinetics of doxorubicin incorporated into albumin microspheres after intrarenal arterial administration.
    Kerr DJ; Willmott N; McKillop JH; Cummings J; Lewi HJ; McArdle CS
    Cancer; 1988 Sep; 62(5):878-83. PubMed ID: 3409170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Albumin microspheres as vehicles for the sustained and controlled release of doxorubicin.
    Jones C; Burton MA; Gray BN
    J Pharm Pharmacol; 1989 Dec; 41(12):813-6. PubMed ID: 2576441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomedical applications of magnetic fluids. III. Antitumour effect of magnetic albumin microsphere-entrapped adriamycin on lung metastasis of AH 7974 in rats.
    Sugibayashi K; Okumura M; Morimoto Y
    Biomaterials; 1982 Jul; 3(3):181-6. PubMed ID: 7115862
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of carrier dose on the multiple tissue disposition of doxorubicin hydrochloride administered via magnetic albumin microspheres in rats.
    Gupta PK; Hung CT
    J Pharm Sci; 1989 Sep; 78(9):745-8. PubMed ID: 2585268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experiment and clinical application of targeting treatment with adriamycin magnetic albumin microspheres in human gastric carcinoma].
    Tao K; Chen D; Wang G; Bai Z; Lu X; Tian Y; Wu Z; Hu F; Nie X
    Zhonghua Wai Ke Za Zhi; 1999 Apr; 37(4):205-7. PubMed ID: 11829819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative disposition of adriamycin delivered via magnetic albumin microspheres in presence and absence of magnetic field in rats.
    Gupta PK; Hung CT
    Life Sci; 1990; 46(7):471-9. PubMed ID: 2304381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery of an anticancer drug and a chemosensitizer to murine breast sarcoma by intratumoral injection of sulfopropyl dextran microspheres.
    Liu Z; Ballinger JR; Rauth AM; Bendayan R; Wu XY
    J Pharm Pharmacol; 2003 Aug; 55(8):1063-73. PubMed ID: 12956895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of regression analysis in the evaluation of tumor response following the administration of adriamycin either as a solution or via albumin microspheres to the rat.
    Gupta PK; Hung CT; Lam FC
    J Pharm Sci; 1990 Jul; 79(7):634-7. PubMed ID: 2398473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A modified method for preparation of adriamycin carried by magnetic albumin microspheres.
    Ma J; Chen D; Tian Y
    J Tongji Med Univ; 2001; 21(3):233-5. PubMed ID: 12539586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo kinetics of magnetically targeted low-dose doxorubicin.
    Senyei AE; Reich SD; Gonczy C; Widder KJ
    J Pharm Sci; 1981 Apr; 70(4):389-91. PubMed ID: 7229949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.